Show simple item record

dc.contributor.authorAtkins, JL
dc.contributor.authorPilling, LC
dc.contributor.authorHeales, CJ
dc.contributor.authorSavage, S
dc.contributor.authorKuo, C-L
dc.contributor.authorKuchel, GA
dc.contributor.authorSteffens, DC
dc.contributor.authorMelzer, D
dc.date.accessioned2021-01-14T09:24:25Z
dc.date.issued2021-01-03
dc.description.abstractBackground: Brain iron deposition occurs in dementia. In European ancestry populations, the HFE p.C282Y variant can cause iron overload and hemochromatosis, mostly in homozygous males. Objective: To estimated p.C282Y associations with brain MRI features plus incident dementia diagnoses during follow-up in a large community cohort. Methods: UK Biobank participants with follow-up hospitalization records (mean 10.5 years). MRI in 206 p.C282Y homozygotes versus 23,349 without variants, including T2 * measures (lower values indicating more iron). Results: European ancestry participants included 2,890 p.C282Y homozygotes. Male p.C282Y homozygotes had lower T2 * measures in areas including the putamen, thalamus, and hippocampus, compared to no HFE mutations. Incident dementia was more common in p.C282Y homozygous men (Hazard Ratio HR = 1.83; 95% CI 1.23 to 2.72, p = 0.003), as was delirium. There were no associations in homozygote women or in heterozygotes. Conclusion: Studies are needed of whether early iron reduction prevents or slows related brain pathologies in male HFE p.C282Y homozygotes.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipUniversity of Connecticut School of Medicineen_GB
dc.description.sponsorshipUniversity of Exeteren_GB
dc.identifier.citationPublished online 3 January 2021en_GB
dc.identifier.doi10.3233/jad-201080
dc.identifier.grantnumberMR/S009892/1en_GB
dc.identifier.urihttp://hdl.handle.net/10871/124389
dc.language.isoenen_GB
dc.publisherIOS Pressen_GB
dc.rights© 2020 – IOS Press and the authors. This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC 4.0).en_GB
dc.subjectCohorten_GB
dc.subjectdementiaen_GB
dc.subjectdeliriumen_GB
dc.subjectgeneen_GB
dc.subjecthemochromatosisen_GB
dc.subjectironen_GB
dc.subjectmutationen_GB
dc.titleHemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohorten_GB
dc.typeArticleen_GB
dc.date.available2021-01-14T09:24:25Z
dc.identifier.issn1387-2877
dc.descriptionThis is the author accepted manuscript. The final version is available on open access from IOS Press via the DOI in this recorden_GB
dc.identifier.journalJournal of Alzheimer's Diseaseen_GB
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/en_GB
dcterms.dateAccepted2020-11-20
exeter.funder::Medical Research Council (MRC)en_GB
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2021-01-03
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-01-14T09:20:53Z
refterms.versionFCDAM
refterms.dateFOA2021-01-14T09:24:44Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2020 – IOS Press and the authors. 
This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC 4.0).
Except where otherwise noted, this item's licence is described as © 2020 – IOS Press and the authors. This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC 4.0).